EPOR and neoplasm: Additionally, some adverse effects of rhEPO may result from stimulation of EPOR signaling in non-erythroid tissues or tumor cells or both151–157, although this point is complicated by technical difficulties in establishing the presence of EPOR in non-erythroid tissues because of non-specific antibody interactions158.